{"entity":{"type":"insider","cik":"0001879253","url":"/insider/0001879253","json_url":"/insider/0001879253.json","name":"Avoro Ventures LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":1,"first":"2026-07-28","last":"2026-07-28","span_basis":"filed_date"},"name_variants":[{"name":"Avoro Ventures LLC","source":"filing","n_filings":1,"first_seen":"2026-07-28","last_seen":"2026-07-28"}],"transactions":[{"id":5832141,"accession":"0000902664-26-003270","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-26-003270","line_url":"/filing/0000902664-26-003270#line-3","is_derivative":false,"issuer_cik":"0001633313","issuer_name":"Scribe Therapeutics, Inc.","issuer_ticker":"SCTX","issuer_name_source":null,"issuer_url":"/issuer/0001633313","owner_cik":null,"owner_name":"Avoro Ventures LLC; Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7905.0,"shares_display":"7,905","price_per_share":18.25,"price_display":"18.25","price_state":"stated","total_value":144266.25,"total_display":"144,266.25","shares_owned_after":3088888.0,"shares_owned_after_display":"3,088,888","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-28","filed_date":"2026-07-28","scope":"insider"},{"id":5832139,"accession":"0000902664-26-003270","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-26-003270","line_url":"/filing/0000902664-26-003270#line-2","is_derivative":false,"issuer_cik":"0001633313","issuer_name":"Scribe Therapeutics, Inc.","issuer_ticker":"SCTX","issuer_name_source":null,"issuer_url":"/issuer/0001633313","owner_cik":null,"owner_name":"Avoro Ventures LLC; Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2333333.0,"shares_display":"2,333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":34999995.0,"total_display":"34,999,995.00","shares_owned_after":3030983.0,"shares_owned_after_display":"3,030,983","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-24","filed_date":"2026-07-28","scope":"insider"},{"id":5832137,"accession":"0000902664-26-003270","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-26-003270","line_url":"/filing/0000902664-26-003270#line-1","is_derivative":false,"issuer_cik":"0001633313","issuer_name":"Scribe Therapeutics, Inc.","issuer_ticker":"SCTX","issuer_name_source":null,"issuer_url":"/issuer/0001633313","owner_cik":null,"owner_name":"Avoro Ventures LLC; Aghazadeh Behzad; Avoro Capital Advisors LLC","owner_url":null,"role":"Director, Ten percent owner, Other","officer_title":null,"security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":22.31,"price_display":"22.31","price_state":"stated","total_value":1115500.0,"total_display":"1,115,500.00","shares_owned_after":3080983.0,"shares_owned_after_display":"3,080,983","ownership_form":"I","is_10b5_1":null,"transaction_date":"2026-07-24","filed_date":"2026-07-28","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001853921","name":"Scribe Therapeutics, Inc.","url":"/issuer/0001853921","role":"Director, Other","n_filings":1,"first_seen":"2026-07-28","last_seen":"2026-07-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001879253","retrieved_at":"2026-08-21T03:45:46+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}